Literature DB >> 32761406

A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging.

Pei-Yao Tao1, Zi-Shu Zhang1, Tian-Cheng Wang1, Meng-Qi Yu1, Yu-Dong Xiao2.   

Abstract

OBJECTIVES: The purpose of the present study is to develop a predictive model for incomplete response (IR) after conventional transarterial chemoembolization (cTACE) for hepatocellular carcinoma (HCC) based on hepatic angiographic and cross-sectional imaging.
METHODS: Sixty patients with 139 target HCC lesions who underwent cTACE from February 2013 to March 2019 were included in this retrospective study. Hepatic angiographic features were identified: the number of feeding arteries, vascularity of the tumor, tumor staining on angiography, vascular lake phenomenon, and hepatic arterio-portal shunt. Cross-sectional imaging features were also identified: tumor extent, location, size, and enhancement pattern. Treatment response was assessed by the modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. Logistic regression analysis was performed to determine the potential predictive factors for treatment response. To validate the predictive value of potential factors, the means of a decision tree were also calculated by Classification and Regression Tree (CART). P < 0.05 was considered statistically significant.
RESULTS: The IR rate was 43.2% (60/139) in the entire study population. Logistic regression analysis showed that a tumor size > 50 mm (P = 0.005; odds ratio, 7.25; 95% CI 1.79-29.33), central location (P = 0.007; odds ratio, 0.14; 95% CI 0.03-0.59), and nondense tumor staining (P < 0.001; odds ratio, 0.08; 95% CI 0.02-0.28) were predictors of IR after cTACE. Decision tree analysis showed a good ability to classify treatment response with an accuracy of 78.4%.
CONCLUSION: Tumor size > 50 mm, central tumor location, and nondense tumor staining were predictors of IR after cTACE. These factors should be taken into consideration when performing cTACE.

Entities:  

Keywords:  Angiography; Carcinoma; Chemoembolization; Ethiodized oil; Hepatocellular; Therapeutic

Mesh:

Year:  2020        PMID: 32761406     DOI: 10.1007/s00261-020-02701-5

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  2 in total

1.  Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma.

Authors:  Jeong Yeop Lee; Byung Chan Lee; Hyoung Ook Kim; Suk Hee Heo; Sang Soo Shin; Yong Yeon Jeong
Journal:  Sci Rep       Date:  2021-12-15       Impact factor: 4.379

2.  Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma.

Authors:  Wei-Li Xia; Shi-Jun Xu; Yuan Guo; Xiao-Hui Zhao; Hong-Tao Hu; Yan Zhao; Quan-Jun Yao; Lin Zheng; Dong-Yang Zhang; Chen-Yang Guo; Wei-Jun Fan; Hai-Liang Li
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.